Charleston, SC, United States of America

Brian Hoel

This inventor holds 6 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignees: Musc Foundation for Research Development, The Penn State Research Foundation, Other. Active years: 2001-2022.

USPTO Granted Patents = 6 

% Patents Active = 66.7

 

Average Co-Inventor Count = 5.4

ph-index = 2

Forward Citations = 279(Granted Patents)


Company Filing History:


Years Active: 2001-2022

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Brian Hoel: Innovator in Antibody Research

Introduction

Brian Hoel is a prominent inventor based in Charleston, SC (US). He has made significant contributions to the field of antibody research, holding a total of 6 patents. His work focuses on developing innovative solutions for diagnosing and treating various diseases.

Latest Patents

Among his latest patents are the anti-nucleolin antibodies, which provide methods for producing these antibodies and utilizing them in the treatment of both malignant and non-malignant diseases. Additionally, he has developed methods for producing human monoclonal antibodies to human nucleolin, which are crucial for diagnosing and treating diseases where nucleolin plays a significant role in the pathophysiology.

Career Highlights

Brian has worked with notable organizations such as the MUSC Foundation for Research Development and the Penn State Research Foundation. His research has paved the way for advancements in medical treatments and diagnostics.

Collaborations

Throughout his career, Brian has collaborated with esteemed colleagues, including Gary A. Clawson and Wei-Hua Pan. These partnerships have enhanced the impact of his research and innovations.

Conclusion

Brian Hoel's contributions to antibody research exemplify his dedication to advancing medical science. His innovative patents and collaborations continue to influence the field positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…